新型硫胺-酸联体作为碳酸酶异酶抑制剂
Mohamed S Bekheit1, Eman Sabry1, Hanan A Mohamed2
1Department of Pesticide Chemistry, National Research Centre, Giza, Egypt.
Drug development research
|November 24, 2023
概括
新的硫胺酸酸盐被合成并测试了抑制人类碳酸 anhydrase (hCA) 酶. 这些化合物显示出高强度和选择性,特别是对hCA XII,这表明潜在的治疗应用.
科学领域:
- 药用化学 医学化学
- 有机合成 有机合成
- 生物化学 生物化学
背景情况:
- 人类碳酸无水酶 (hCA) 是参与各种生理过程的关键酶.
- hCA活动的失调与多种疾病有关,使它们成为有吸引力的治疗点.
- 开发针对特定hCA异型的选择性抑制剂对于向疗法至关重要.
研究的目的:
- 通过单卡巴赫尼克-菲尔兹反应合成新的硫胺-酸化合物.
- 评估这些化合物的抑制活性和选择性与四种人类碳酸酶异型 (hCA I,II,IX和XII) 相比.
- 通过分子对接,研究强效抑制剂与hCA XII活性部位的结合相互作用.
主要方法:
- 一个的卡巴赫尼克-菲尔兹反应催化由甲 (III) 三酸盐合成硫胺-酸盐.
- 使用光谱学研究 (NMR,IR,质谱学) 和单晶X射线衍射的结构阐明.
- 酶抑制试验用于确定针对hCA I,II,IX和XII的抑制常数 (Ki).
- 分子对接模拟以分析hCA XII活性部位内的结合模式.
主要成果:
- 一系列的硫胺-酸盐 (3a-3p) 在良好的优异产量 (78%-91%) 中被合成.
- 化合物显示出对hCA XII的强烈抑制,Ki值在5.1至51.1nM之间.
- 化合物3l和3p对hCA XII比hCA I和II具有显著的选择性.
- 分子对接揭示了关键相互作用,包括硫胺NH组与Zn2+的协调,与Thr200的键,以及与Leu198的疏水相互作用.
结论:
- 开发的单合成方法可以有效地生产新的硫胺-酸盐.
- 这些化合物代表了开发选择性hCA XII抑制剂的有希望的线索.
- 观察到的结合相互作用为抑制和选择性的机制提供了洞察力,指导着未来的药物设计.
相关概念视频
Antihypertensive Drugs: Thiazide-Class Diuretics
688
Thiazide diuretics are sulfonamide derivatives featuring a benzothiadiazine ring system in their molecular structure. Based on this structure, thiazide diuretics can be categorized into two groups: thiazide-type and thiazide-like diuretics. Thiazide-type diuretics, including hydrochlorothiazide and chlorothiazide, consist of a benzothiadiazine backbone with an attached sulfonamide group. Thiazide-like diuretics, such as chlorthalidone and indapamide, lack the thiazide ring but demonstrate...
688
Phase II Reactions: Sulfation and Conjugation with α-Amino Acids
251
Sulfation and α-amino acid conjugation are two critical biotransformation reactions in drug metabolism. Sulfation, a phase II biotransformation reaction, involves adding a polar sulfate group to a drug, enhancing its water solubility and promoting excretion. This process can either co-occur with or occur independently of glucuronidation. Nonmicrosomal sulfotransferase enzymes catalyze the process. The reaction involves 3'-phosphoadenosine-5'-phosphosulfate or PAPS coenzyme...
251
Drug Metabolism: Phase II Reactions
3.8K
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
3.8K
Phase II Reactions: Miscellaneous Conjugation Reactions
63
Phase II biotransformations are detoxification mechanisms that conjugate xenobiotics with endogenous substances, neutralizing their toxicity.
A key example involves the conjugation of cyanide ions, which impair cellular respiration and alter hemoglobin into non-oxygen-carrying cyanmethemoglobin. To neutralize this threat, a sulfur atom from thiosulphate is transferred to the cyanide ion, catalyzed by the enzyme rhodanese, resulting in an inactive compound called thiocyanate. The production of...
A key example involves the conjugation of cyanide ions, which impair cellular respiration and alter hemoglobin into non-oxygen-carrying cyanmethemoglobin. To neutralize this threat, a sulfur atom from thiosulphate is transferred to the cyanide ion, catalyzed by the enzyme rhodanese, resulting in an inactive compound called thiocyanate. The production of...
63
Aryldiazonium Salts to Azo Dyes: Diazo Coupling
2.9K
The reaction of weakly electrophilic aryldiazonium (also called arenediazonium) salts with highly activated aromatic compounds leads to the formation of products with an —N=N— link, called an azo linkage. This reaction, presented in Figure 1, is known as diazo coupling and occurs without the loss of the nitrogen atoms of the aryldiazonium salt. Highly activated aromatic compounds such as phenols or arylamines favor the diazo coupling reaction. The coupling generally occurs at the...
2.9K
Phase II Conjugation Reactions: Overview
216
Conjugation, a key component of phase II biotransformation reactions, is a vital process in drug detoxification. It involves transferring endogenous substances like glucuronic acid, sulfate, and glycine to drugs or their metabolites formed in phase I reactions. These conjugation reactions, often catalyzed by specific enzymes, transform potentially harmful metabolites into inactive, water-soluble forms easily excreted in urine or bile. By enhancing polarity and eliminating pharmacological...
216


